O
Oche Agbaji
Researcher at University of Jos
Publications - 106
Citations - 1875
Oche Agbaji is an academic researcher from University of Jos. The author has contributed to research in topics: Population & Viral load. The author has an hindex of 17, co-authored 99 publications receiving 1636 citations. Previous affiliations of Oche Agbaji include College of Health Sciences, Bahrain.
Papers
More filters
Journal ArticleDOI
Explaining Adherence Success in Sub-Saharan Africa: An Ethnographic Study
Norma C. Ware,John Idoko,Sylvia Kaaya,Irene Andia Biraro,Monique A. Wyatt,Oche Agbaji,Guerino Chalamilla,David R. Bangsberg +7 more
TL;DR: An explanation and theoretical model of ART adherence success in sub-Saharan Africa can be explained as a means of fulfilling social responsibilities and thus preserving social capital in essential relationships.
Journal ArticleDOI
Toward an understanding of disengagement from HIV treatment and care in sub-Saharan Africa: a qualitative study.
Norma C. Ware,Monique A. Wyatt,Elvin Geng,Sylvia Kaaya,Oche Agbaji,Winnie Muyindike,Guerino Chalamilla,Patricia A. Agaba +7 more
TL;DR: A large qualitative study among patients in HIV treatment programs in sub-Saharan Africa to investigate reasons for missed visits and provide an explanation for disengagement from care finds no cause for concern.
Journal ArticleDOI
Immunologic Criteria Are Poor Predictors of Virologic Outcome: Implications for HIV Treatment Monitoring in Resource-Limited Settings
Holly Rawizza,Beth Chaplin,Seema T. Meloni,Geoffrey Eisen,Tara Rao,Jean-Louis Sankalé,Abdoulaye Dieng-Sarr,Oche Agbaji,D. I. Onwujekwe,Wadzani Gashau,Reuben Nkado,Ernest Ekong,Prosper Okonkwo,Robert L. Murphy,Phyllis J. Kanki +14 more
TL;DR: For patients with both virologic and immunologic failure, VL criteria identified failure significantly earlier than CD4 cell criteria (median, 10.4 vs 15.6 months; P < .0001).
Journal ArticleDOI
Assessing the viorologic and adherence benefits of patient-selected HIV treatment partners in a resource-limited setting.
Babafemi Taiwo,John A Idoko,Leah J. Welty,Ihedinachi Otoh,Grace Job,Paul G. Iyaji,Oche Agbaji,Patricia A. Agaba,Robert L. Murphy +8 more
TL;DR: Use of patient-selected treatment partners was associated with improved drug pickup adherence and initial virologic success but had no durable effect on attaining undetectable viral load.
Journal ArticleDOI
Continued Transmission of Zika Virus in Humans in West Africa, 1992-2016.
Bobby Brooke Herrera,Charlotte A. Chang,Donald J. Hamel,Souleymane Mboup,Daouda Ndiaye,Godwin E. Imade,Jonathan Okpokwu,Oche Agbaji,Amy K. Bei,Amy K. Bei,Phyllis J. Kanki +10 more
TL;DR: Evidence that ZIKV has been silently circulating in West Africa for 2 decades is provided, with evidence that the ZIKVs belonged to the African lineage.